Monday (16.06.2024), 05:30 - 09:30 UTC
Our system will be temporarily unavailable due to new features implementation
It is used for locally advanced or metastatic NSCLC that has specific EGFR exon 19 deletions or exon 21 (L858R) substitution mutations. It is used for both first-line treatment and as maintenance therapy after previous chemotherapy.
Tarceva is a targeted therapy drug, specifically an EGFR inhibitor (Epidermal Growth Factor Receptor tyrosine kinase inhibitor).
While effective, Tarceva can cause significant side effects that require monitoring: Erlotinib (Tarceva) - Cancer Research UK
It works by blocking chemical signals that cause cancer cells to grow and divide.
It is approved for use in combination with gemcitabine chemotherapy for patients with advanced, previously untreated pancreatic cancer. Common Side Effects
Based on the request for information regarding , this write-up covers the key aspects of the drug, primarily used for targeted cancer therapy. What is Tarceva (Erlotinib)?
It is used for locally advanced or metastatic NSCLC that has specific EGFR exon 19 deletions or exon 21 (L858R) substitution mutations. It is used for both first-line treatment and as maintenance therapy after previous chemotherapy.
Tarceva is a targeted therapy drug, specifically an EGFR inhibitor (Epidermal Growth Factor Receptor tyrosine kinase inhibitor).
While effective, Tarceva can cause significant side effects that require monitoring: Erlotinib (Tarceva) - Cancer Research UK
It works by blocking chemical signals that cause cancer cells to grow and divide.
It is approved for use in combination with gemcitabine chemotherapy for patients with advanced, previously untreated pancreatic cancer. Common Side Effects
Based on the request for information regarding , this write-up covers the key aspects of the drug, primarily used for targeted cancer therapy. What is Tarceva (Erlotinib)?

years
of experience
users trusted
our solutions
team
of experts
processed
documents yearly